These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19966863)

  • 21. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
    Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
    Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of in vivo gene delivery by restriction enzyme PCR generated polymorphism.
    Fichera A; Guo Y; Romero L; Michelassi F; Arenas RB
    J Surg Res; 1997 Apr; 69(1):188-92. PubMed ID: 9202668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model.
    Hardiman KM; Liu J; Feng Y; Greenson JK; Fearon ER
    PLoS One; 2014; 9(4):e96023. PubMed ID: 24763434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile.
    Churchill M; Chadburn A; Bilinski RT; Bertagnolli MM
    J Surg Res; 2000 Apr; 89(2):169-75. PubMed ID: 10729246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production.
    Ahn B; Ohshima H
    Cancer Res; 2001 Dec; 61(23):8357-60. PubMed ID: 11731407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
    Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
    Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Betacellulin stimulates growth of the mouse intestinal epithelium and increases adenoma multiplicity in Apc+/Min mice.
    Dahlhoff M; Horst D; Gerhard M; Kolligs FT; Wolf E; Schneider MR
    FEBS Lett; 2008 Aug; 582(19):2911-5. PubMed ID: 18656477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling.
    Wei C; Amos CI; Zhang N; Wang X; Rashid A; Walker CL; Behringer RR; Frazier ML
    Clin Cancer Res; 2008 Feb; 14(4):1167-71. PubMed ID: 18281551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered SK3/KCa2.3-mediated migration in adenomatous polyposis coli (Apc) mutated mouse colon epithelial cells.
    Potier M; Tran TA; Chantome A; Girault A; Joulin V; Bougnoux P; Vandier C; Pierre F
    Biochem Biophys Res Commun; 2010 Jun; 397(1):42-7. PubMed ID: 20519134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of both APC alleles in human and mouse tumors.
    Levy DB; Smith KJ; Beazer-Barclay Y; Hamilton SR; Vogelstein B; Kinzler KW
    Cancer Res; 1994 Nov; 54(22):5953-8. PubMed ID: 7954428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.
    Yamada Y; Hata K; Hirose Y; Hara A; Sugie S; Kuno T; Yoshimi N; Tanaka T; Mori H
    Cancer Res; 2002 Nov; 62(22):6367-70. PubMed ID: 12438216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.
    Wechter WJ; Kantoci D; Murray ED; Quiggle DD; Leipold DD; Gibson KM; McCracken JD
    Cancer Res; 1997 Oct; 57(19):4316-24. PubMed ID: 9331093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.
    Schmelz EM; Roberts PC; Kustin EM; Lemonnier LA; Sullards MC; Dillehay DL; Merrill AH
    Cancer Res; 2001 Sep; 61(18):6723-9. PubMed ID: 11559543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapamycin Extends Life Span in Apc
    Parihar M; Dodds SG; Hubbard G; Javors MA; Strong R; Hasty P; Sharp ZD
    Clin Colorectal Cancer; 2021 Mar; 20(1):e61-e70. PubMed ID: 33132009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
    Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice.
    Xiao H; Yin W; Khan MA; Gulen MF; Zhou H; Sham HP; Jacobson K; Vallance BA; Li X
    Gastroenterology; 2010 Aug; 139(2):574-85. PubMed ID: 20416302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential role of P-gp for flavone-induced diminished apoptosis and increased adenoma size in the small intestine of APC(min/+) mice.
    Schumacher M; Hautzinger A; Rossmann A; Holzhauser S; Popovic D; Hertrampf A; Oesterle D; Spiller C; Boll M; Wenzel U
    Cancer Invest; 2011 Jul; 29(6):396-404. PubMed ID: 21649465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SGK1-dependent intestinal tumor growth in APC-deficient mice.
    Wang K; Gu S; Nasir O; Föller M; Ackermann TF; Klingel K; Kandolf R; Kuhl D; Stournaras C; Lang F
    Cell Physiol Biochem; 2010; 25(2-3):271-8. PubMed ID: 20110688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.